stockrowPerrigo Company plc (PRGO) vs Xeris Biopharma Holdings, Inc. (XERS)
- Perrigo Company plc PRGO 15.78 +0.45%
- Xeris Biopharma Holdings, Inc. XERS 15.16 +15.90%
Perrigo Company plc and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc and Xeris Biopharma Holdings, Inc. are of similar size ($2.4B and $2.2B). Xeris Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 38.4% against −4.47%. Xeris Biopharma Holdings, Inc. has the higher net margin (−1.76% vs −43.3%) and the higher return on invested capital (27.2% vs −19.0%). Across the 19 metrics below, Xeris Biopharma Holdings, Inc. leads on 11 and Perrigo Company plc on 8.
Valuation
Profitability
| Metric | PRGO | XERS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 32.33% | 87.38% | 53.51% |
| Operating margin | (39.43%) | 12.70% | 0.00% |
| Net margin | (43.27%) | (1.76%) | (2.31%) |
| Free cash flow margin | 4.11% | 20.00% | 0.00% |
| Return on equity | (51.39%) | (27.11%) | (0.80%) |
| Return on assets | (20.15%) | (1.64%) | (1.67%) |
| Return on invested capital | (19.03%) | 27.22% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack